Your doctor probably does not know that bromocriptine is approved for the treatment of type II diabetes. Even if she/he did know about it, the cited mechanism of action is "unkown" or a "mystery". But at least, it is a step in the right direction - i.e. away from serotonin, estrogen and histamine.
This study from 2015, found that Cycloset (bromocriptine) also reduced the CVD events for all type II diabetic patients, even in those with "normal" blood sugar levels.
Bromocriptine-QR for Prevention of Cardiovascular Events in Type 2 Diabetes
"...
This study from 2015, found that Cycloset (bromocriptine) also reduced the CVD events for all type II diabetic patients, even in those with "normal" blood sugar levels.
Bromocriptine-QR for Prevention of Cardiovascular Events in Type 2 Diabetes
"...
- There may be biochemical pathologies in the T2DM population aside from hyperglycemia, hyperlipidemia and hypertension putting them at risk for CVD events.
- There are likely benefits of bromocriptine-QR beyond its glucose-lowering effect, which reduces risk of CVD events T2DM.
- Patients with T2DM with good glycemic control may benefit from the addition of bromocriptine-QR to reduce their risk of CVD events without the risk of serious adverse events.